Search Results - "Bruseo, C W"
-
1
Characterization of a potent and selective endothelin-B receptor antagonist, IRL 2500
Published in Journal of cardiovascular pharmacology (1995)“…IRL 2500 [N-(3,5-dimethylbenzoyl)-N-methyl-(D)-(4-phenylphenyl)-alany l-L- tryptophan] inhibited the binding of [125I]-endothelin-1 (ET-1) to human ETB (IC50…”
Get more information
Journal Article -
2
Design and Synthesis of a Potent and Selective Endothelin-Converting Enzyme Inhibitor, CGS 35066
Published in Journal of cardiovascular pharmacology (2000)“…CGS 26303 has previously been shown to inhibit human endothelin converting enzyme-1 (ECE-1) with an IC50 of 410 nM and to be efficacious in several animal…”
Get full text
Journal Article -
3
Cgs 34043: A non-peptidic, potent and long-acting dual inhibitor of endothelin converting enzyme-1 and neutral endopeptidase 24.11
Published in Life sciences (1973) (2000)“…Endothelin-1 (ET-1) is a potent vasoconstrictor. Its biosynthesis is catalyzed by endothelin converting enzyme (ECE). In contrast, atrial natriuretic peptide…”
Get full text
Journal Article -
4
Synthesis and biological activity of novel potent endothelin-converting enzyme-1 inhibitors
Published in Bioorganic & medicinal chemistry letters (12-02-2001)“…Through directed screening of metalloprotease inhibitors, CGS 30084 (1) has been identified as a potent endothelin-converting enzyme-1 (ECE-1) inhibitor in…”
Get full text
Journal Article -
5
Pharmacological Properties of CGS 35066, a Potent and Selective Endothelin-Converting Enzyme Inhibitor, in Conscious Rats
Published in Journal of cardiovascular pharmacology (01-11-2000)“…The purpose of this study was to examine the pharmacologic properties of CGS 35066, a novel aminophosphonate inhibitor of endothelin-converting enzyme-1…”
Get full text
Journal Article -
6
CGS 35601 and its Orally Active Prodrug CGS 37808 as Triple Inhibitors of Endothelin-converting Enzyme-1, Neutral Endopeptidase 24.11, and Angiotensin-converting Enzyme
Published in Journal of cardiovascular pharmacology (01-11-2004)“…CGS 35601 is a potent triple inhibitor of endothelinconverting enzyme-1, neutral endopeptidase 24.11, and angiotensinconverting enzyme. It inhibited the…”
Get full text
Journal Article -
7
CGS 34226, a thiol-based dual inhibitor of endothelin converting enzyme-1 and neutral endopeptidase 24.11
Published in Clinical science (1979) (01-08-2002)“…Endothelins (ETs) are potent vasoconstrictors and have been implicated in the pathogenesis of various cardiovascular and renal diseases. In contrast, atrial…”
Get more information
Journal Article -
8
Synthesis and biological activity of potent heterocyclic thiol-based inhibitors of endothelin-converting enzyme-1
Published in Bioorganic & medicinal chemistry letters (04-11-2002)“…Directed screening of metalloprotease inhibitors identified CGS 30084 ( 1) as a potent inhibitor of endothelin-converting enzyme-1 (ECE-1) in vitro (IC 50=77…”
Get full text
Journal Article -
9
Effects of the ECE/NEP inhibitor CGS 34225 on the big ET-1-induced pressor response and plasma atrial natriuretic peptide concentration in conscious rats
Published in Clinical science (1979) (01-08-2002)“…CGS 34226 is a thiol-containing, potent dual inhibitor of endothelin converting enzyme-1 (ECE-1) and neutral endopeptidase 24.11 (NEP) with IC(50) values of 11…”
Get more information
Journal Article -
10
Pharmacological Properties of CGS 35066, a Potent and Selective Endothelin-Converting Enzyme Inhibitor, in Conscious Rats
Published in Journal of cardiovascular pharmacology (2000)“…The purpose of this study was to examine the pharmacologic properties of CGS 35066, a novel aminophosphonate inhibitor of endothelin-converting enzyme-1…”
Get full text
Journal Article -
11
Dipeptide sulfonamides as endothelin ETA/ETB receptor antagonists
Published in Canadian journal of physiology and pharmacology (01-05-2002)“…Endothelin-1 (ET-1) is a potent mitogen and modulator of vascular tone. It is synthesized and released from endothelial cells and acts upon two receptor…”
Get more information
Journal Article